Company: PTHS
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001753926-25-001326
Chunk: 239

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part II, Item 3
Chunk 239
---
 10.10
     
    Pelthos Therapeutics Amended and Restated 2023 Equity Incentive Plan. (filed as Exhibit 10.14 to Registrant’s Current Report on Form 8-K, filed with the SEC on July 1, 2025 and incorporated by reference herein).

    10.11
     
    Merger Agreement Waiver, dated as of July 1, 2025, by and among Channel Therapeutics Corporation, CHRO Merger Sub Inc., LNHC, Inc. and Ligand Pharmaceuticals Incorporated. (filed as Exhibit 2.2 to Registrant’s Current Report on Form 8-K, filed with the SEC on July 1, 2025 and incorporated by reference herein).

    10.12
     
    Amendment No. 1 to Securities Purchase Agreement, dated as of July 1, 2025, by and among Channel Therapeutics Corporation, LNHC Inc., and each of the investors thereto. (filed as Exhibit 10.6 to Registrant’s Current Report on Form 8-K, filed with the SEC on July 1, 2025 and incorporated by reference herein).

    10.13
     
    Contribution Agreement, dated as of July 1, 2025, by and between Channel Therapeutics Corporation and Channel Pharmaceutical Corporation. (filed as Exhibit 10.10 to Registrant’s Current Report on Form 8-K, filed with the SEC on July 1, 2025 and incorporated by reference herein).

    10.14
     
    Intellectual Property Assignment and Assumption Agreement, dated as of July 1, 2025, by and between Channel Therapeutics Corporation and Channel Pharmaceutical Corporation. (filed as Exhibit 10.11 to Registrant’s Current Report on Form 8-K, filed with the SEC on July 1, 2025 and incorporated by reference herein).

    10.15
     
    Purchase and Sale Agreement, dated as of July 1, 2025, by and among Channel Therapeutics Corporation and LNHC, Inc., as the Seller Parties and Nomis RoyaltyVest LLC, as the Purchaser. (filed as Exhibit 10.12 to Registrant’s Current Report on Form 8-K, filed with the SEC on July 1, 2025 and incorporated by reference herein).

    10.16
     
    Purchase and Sale Agreement, dated as of July